\begin{figure}[htbp]
\section*{NF1}
\centering
\begin{subfigure}[b]{0.5\textwidth}
\centering
\includegraphics[width=\textwidth]{ img/NF1_protein_diagram.pdf} 
\captionsetup{justification=raggedright,singlelinecheck=false}
\caption{Distribution of variants in NF1}
\end{subfigure}


\begin{subfigure}[b]{0.95\textwidth}
\centering
\resizebox{\textwidth}{!}{
\begin{tabular}{llllrr}
\toprule
HPO term & Missense & other & p-value & adj. p-value\\
\midrule
Freckling [HP:0001480] & 181/278 (65\%) & 96/117 (82\%) & $7.20\times 10^{-4}$ & 0.009\\
Glioma [HP:0009733] & 35/282 (12\%) & 11/27 (41\%) & $5.31\times 10^{-4}$ & 0.009\\
Lipoma [HP:0012032] & 4/277 (1\%) & 5/51 (10\%) & 0.006 & 0.030\\
Spinal neurofibroma [HP:0009735] & 23/228 (10\%) & 0/67 (0\%) & 0.003 & 0.021\\
Neurofibroma by anatomical location [HP:0034761] & 23/206 (11\%) & 0/67 (0\%) & 0.002 & 0.015\\
\bottomrule
\end{tabular}
}
\captionsetup{justification=raggedright,singlelinecheck=false}
\caption{         Fisher Exact Test performed to compare HPO annotation frequency with respect to Missense and other. Total of
        26 tests were performed. }
\end{subfigure}
\vspace{2em}
\begin{subfigure}[b]{0.95\textwidth}
\centering
\resizebox{\textwidth}{!}{
\begin{tabular}{llllrr}
\toprule
HPO term & p.Arg1830 & other & p-value & adj. p-value\\
\midrule
Freckling [HP:0001480] & 76/133 (57\%) & 201/262 (77\%) & $1.11\times 10^{-4}$ & $2.99\times 10^{-4}$\\
Lisch nodules [HP:0009737] & 11/91 (12\%) & 72/193 (37\%) & $6.58\times 10^{-6}$ & $1.97\times 10^{-5}$\\
Neurofibroma [HP:0001067] & 5/133 (4\%) & 153/275 (56\%) & $2.48\times 10^{-28}$ & $6.71\times 10^{-27}$\\
Axillary freckling [HP:0000997] & 20/79 (25\%) & 105/175 (60\%) & $3.66\times 10^{-7}$ & $1.41\times 10^{-6}$\\
Inguinal freckling [HP:0030052] & 8/79 (10\%) & 84/170 (49\%) & $4.86\times 10^{-10}$ & $3.28\times 10^{-9}$\\
Plexiform neurofibroma [HP:0009732] & 0/135 (0\%) & 68/255 (27\%) & $1.45\times 10^{-14}$ & $1.96\times 10^{-13}$\\
Scoliosis [HP:0002650] & 8/125 (6\%) & 48/240 (20\%) & $4.02\times 10^{-4}$ & $9.87\times 10^{-4}$\\
Optic nerve glioma [HP:0009734] & 0/135 (0\%) & 39/217 (18\%) & $1.92\times 10^{-9}$ & $1.04\times 10^{-8}$\\
Glioma [HP:0009733] & 2/136 (1\%) & 44/173 (25\%) & $2.36\times 10^{-10}$ & $2.13\times 10^{-9}$\\
Spinal neurofibroma [HP:0009735] & 0/128 (0\%) & 23/167 (14\%) & $1.90\times 10^{-6}$ & $6.42\times 10^{-6}$\\
Neurofibroma by anatomical location [HP:0034761] & 0/128 (0\%) & 23/145 (16\%) & $2.05\times 10^{-7}$ & $9.23\times 10^{-7}$\\
Pulmonic stenosis [HP:0001642] & 13/105 (12\%) & 5/162 (3\%) & 0.005 & 0.011\\
\bottomrule
\end{tabular}
}
\captionsetup{justification=raggedright,singlelinecheck=false}
\caption{         Fisher Exact Test performed to compare HPO annotation frequency with respect to p.Arg1830 and other. Total of
        27 tests were performed. }
\end{subfigure}
\vspace{2em}
\begin{subfigure}[b]{0.95\textwidth}
\centering
\resizebox{\textwidth}{!}{
\begin{tabular}{llllrr}
\toprule
HPO term & Met992del & other & p-value & adj. p-value\\
\midrule
Lisch nodules [HP:0009737] & 3/36 (8\%) & 80/248 (32\%) & 0.003 & 0.008\\
Neurofibroma [HP:0001067] & 0/44 (0\%) & 158/364 (43\%) & $1.68\times 10^{-10}$ & $2.68\times 10^{-9}$\\
Axillary freckling [HP:0000997] & 0/14 (0\%) & 125/240 (52\%) & $8.57\times 10^{-5}$ & $6.86\times 10^{-4}$\\
Inguinal freckling [HP:0030052] & 0/14 (0\%) & 92/235 (39\%) & 0.003 & 0.008\\
Plexiform neurofibroma [HP:0009732] & 0/44 (0\%) & 68/346 (20\%) & $2.00\times 10^{-4}$ & 0.001\\
Lipoma [HP:0012032] & 5/44 (11\%) & 4/284 (1\%) & 0.003 & 0.008\\
\bottomrule
\end{tabular}
}
\captionsetup{justification=raggedright,singlelinecheck=false}
\caption{Fisher Exact Test performed to compare HPO annotation frequency with respect to Met992del and other. Total of
        16 tests were performed.}
\end{subfigure}

\end{figure}
\begin{figure}[htbp]
\section*{NF1 (part 2)}


\vspace{2em}
\begin{subfigure}[b]{0.95\textwidth}
\centering
\resizebox{\textwidth}{!}{
\begin{tabular}{llllrr}
\toprule
HPO term & Leu847Pro & other & p-value & adj. p-value\\
\midrule
Freckling [HP:0001480] & 54/64 (84\%) & 223/331 (67\%) & 0.007 & 0.023\\
Lisch nodules [HP:0009737] & 22/42 (52\%) & 61/242 (25\%) & $7.48\times 10^{-4}$ & 0.004\\
Neurofibroma [HP:0001067] & 47/67 (70\%) & 111/341 (33\%) & $1.58\times 10^{-8}$ & $2.14\times 10^{-7}$\\
Axillary freckling [HP:0000997] & 50/61 (82\%) & 75/193 (39\%) & $3.55\times 10^{-9}$ & $9.58\times 10^{-8}$\\
Inguinal freckling [HP:0030052] & 34/60 (57\%) & 58/189 (31\%) & $3.92\times 10^{-4}$ & 0.003\\
Plexiform neurofibroma [HP:0009732] & 24/65 (37\%) & 44/325 (14\%) & $4.45\times 10^{-5}$ & $4.00\times 10^{-4}$\\
Optic nerve glioma [HP:0009734] & 15/65 (23\%) & 24/287 (8\%) & 0.002 & 0.008\\
Glioma [HP:0009733] & 18/67 (27\%) & 28/242 (12\%) & 0.003 & 0.013\\
Neurofibroma by anatomical location [HP:0034761] & 6/26 (23\%) & 17/247 (7\%) & 0.014 & 0.041\\
\bottomrule
\end{tabular}
}
\captionsetup{justification=raggedright,singlelinecheck=false}
\caption{Fisher Exact Test performed to compare HPO annotation frequency with respect to Leu847Pro and other. Total of
        27 tests were performed. }
\end{subfigure}
\vspace{2em}
\begin{subfigure}[b]{0.95\textwidth}
\centering
\resizebox{\textwidth}{!}{
\begin{tabular}{llllrr}
\toprule
HPO term & SV & other & p-value & adj. p-value\\
\midrule
Freckling [HP:0001480] & 53/60 (88\%) & 224/335 (67\%) & $6.36\times 10^{-4}$ & 0.005\\
Neurofibroma [HP:0001067] & 41/60 (68\%) & 117/348 (34\%) & $6.03\times 10^{-7}$ & $1.39\times 10^{-5}$\\
Plexiform neurofibroma [HP:0009732] & 16/50 (32\%) & 52/340 (15\%) & 0.008 & 0.037\\
Scoliosis [HP:0002650] & 18/57 (32\%) & 38/308 (12\%) & $9.71\times 10^{-4}$ & 0.006\\
Glioma [HP:0009733] & 8/11 (73\%) & 38/298 (13\%) & $1.60\times 10^{-5}$ & $1.84\times 10^{-4}$\\
\bottomrule
\end{tabular}
}
\captionsetup{justification=raggedright,singlelinecheck=false}
\caption{         Fisher Exact Test performed to compare HPO annotation frequency with respect to SV and other. Total of
        23 tests were performed. }
\end{subfigure}
\vspace{2em}

\caption{ The cohort comprised 419 individuals (192 females, 169 males, 58 with unknown sex). A total of 36 HPO terms were used to annotate the cohort. Disease diagnosis: Neurofibromatosis, type 1 (OMIM:162200). A substantial body of literature exists about genotype-phenotype correlations. The correlations described in this notebook
have been previously reported \cite{PMID_26178382,PMID_17160901,PMID_20513137}.
 A total of 36 unique variant alleles were found in \textit{NF1} (transcript: \texttt{NM\_001042492.3}, protein id: \texttt{NP\_001035957.1}).}
\end{figure}
